Melanin-like Nanoparticles As a Potential Novel Therapeutic Approach in ADPKD
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Hansen J, Kaiser F, Leyendecker P, Stuven B, Krause J, Derakhshandeh F
. A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation. EMBO Rep. 2022; 23(8):e54315.
PMC: 9346484.
DOI: 10.15252/embr.202154315.
View
2.
Padovano V, Podrini C, Boletta A, Caplan M
. Metabolism and mitochondria in polycystic kidney disease research and therapy. Nat Rev Nephrol. 2018; 14(11):678-687.
DOI: 10.1038/s41581-018-0051-1.
View
3.
Zhou X, Torres V
. Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling. Front Mol Biosci. 2022; 9:981963.
PMC: 9478168.
DOI: 10.3389/fmolb.2022.981963.
View
4.
Cassina L, Chiaravalli M, Boletta A
. Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression. FASEB J. 2020; 34(5):6493-6507.
DOI: 10.1096/fj.201901739RR.
View
5.
Sun Y, Zou Q, Yu H, Yi X, Dou X, Yang Y
. Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB. EMBO Mol Med. 2024; 17(1):169-192.
PMC: 11730739.
DOI: 10.1038/s44321-024-00167-2.
View